Latest Orbis Medicines news, funding rounds and robotics & AI coverage. 1 article tracked by The Robotics Media.
Orbis Medicines, headquartered in Copenhagen with a chemistry hub in Lausanne, is building orally bioavailable macrocycle medicines through its nGen generative AI drug discovery platform. The company synthesises and screens massive proprietary macrocycle libra...